您的位置: 首页 > 农业专利 > 详情页

Use of cannabinoids in treatment of epilepsy
专利权人:
GW Research Limited
发明人:
Geoffrey Guy,Stephen Wright,Alice Mead,Anne Comi
申请号:
GB201605448
公开号:
GB2548873A
申请日:
2016.03.31
申请国别(地区):
GB
年份:
2017
代理人:
摘要:
The use of the cannabinoid cannabidiol (CBD) in the treatment of Sturge Weber syndrome. The invention is particularly directed to reducing either seizure ornon-seizure symptoms in patients suffering with Sturge Weber syndrome. Cannabidiol may be used in combination with one or more concomitant anti-epileptic drugs for the treatment of Sturge Weber syndrome. In some instances the CBD used is in the form of a highly purified extract of cannabis such that the CBD is present at greater than 98% of the total extract (w/w). In some cases the cannabinoid tetrahydrocannabinol (THC) has been substantially removed, to a level of not more than 0.15% (w/w) and the propyl analogue of CBD, cannabidivarin, (CBDV) is present in amounts of up to 1%. Alternatively, the CBD may be a synthetically produced CBD.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充